Fatigue treatment study for multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This trial tests a brain stimulation therapy designed to reduce fatigue in people with multiple sclerosis. If you experience moderate to severe fatigue and have a stable medication routine, this study might help determine if a non-invasive treatment can improve your energy levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with relapsing-remitting or secondary progressive MS for at least 3 months.
- You have moderate to severe fatigue, scoring above 53 on a fatigue questionnaire.
- Your MS medication has been stable for the past 3 months.
- You have not had an MS relapse or taken steroids in the past 3 months.
- You are not currently being treated for fatigue, and have not received such treatment in the last 3 months.
- You have no metal implants, pacemaker, or other devices that are not compatible with MRI scanning.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment called transcranial magnetic stimulation (TMS), which uses magnetic pulses to stimulate the brain and may help relieve depression in people with multiple sclerosis (MS). If you have MS and moderate to severe depression that hasn't improved with other treatments, this trial might be an option.
This trial tests if a personalized home training program can help reduce severe fatigue in people with relapsing-remitting MS who were recently diagnosed. You'll use a phone app to do exercises designed for you, and researchers will check your energy levels over time.
This study tests a non-invasive brain stimulation treatment called repetitive transcranial magnetic stimulation (rTMS) to see if it can reduce fatigue after a stroke. If you have ongoing tiredness that started or got worse after your stroke, this treatment might help.
This trial tests an online self-management program to help reduce fatigue in people with MS. You'll use a website or app over 24 weeks, and researchers will check how well it works.
This study tests two non-invasive brain stimulation treatments—TMS and tDCS—to see if they can reduce fatigue in people with relapsing-remitting MS. The goal is to find a safe, drug-free way to help you feel less tired.
This study uses a safe, non-invasive brain stimulation technique to see if it can reduce fatigue in people with relapsing-remitting MS. It compares people with and without fatigue to understand how the brain is affected.
Hear when a new Multiple Sclerosis, Relapsing-Remitting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.